Latest News
Personalis, Inc.
- New Products: Pillar Biosciences, Freenome, Parse Biosciences, Ultima Genomics, Personalis, More
- Personalis, Inc. Estimates – XETR:04X
- PSNL Stock Notification: Personalis, Inc. is being Investigated after the $16.25 per share Merger Deal Announced – Investors are Alerted to Contact BFA Law
- Personalis, Inc. Revenue Breakdown – XETR:04X
- Personalis - Announces Commercial Launch Of Real-Time Variant Tracker In Next Personal Mrd Test
- Personalis Inc. (PSNL) Slips to $15.65 as Shares Pull Back Within Recent Range - Relative Volume
- In Brief This Week: Personalis, Tempus, AstraZeneca, Summit, ARUP, FDA, Agilent, Abbvie, More
- Why is Personalis stock sliding today?
- Personalis: The Wrong Side Of The Merger (NASDAQ:PSNL)
- Personalis CEO Christopher Hall sells $120,984 in company stock By Investing.com
- Form 4 Personalis Inc For: 27 September By Investing.com
- Personalis president & CMO Chen sells $64,847 of PSNL stock
Headlines from the last 30 days, linking to the original publishers. See all market news →